Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
23.05.24
/
50%
€44.80
Target price
23.05.25
€64.64
Performance (%)
-42.86%
End price
24.05.25
€25.60
Summary
This prediction ended on 24.05.25 with a price of €25.60. The BUY prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc performed very badly with a performance of -42.86%. Morgan_Stanley has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 0.797% | 0.797% | 198.049% |
| iShares Core DAX® | 0,63 % | 4,95 % | 8,66 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % | 26,82 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % | 48,19 % |
| iShares S&P 500 | 0,63 % | 1,38 % | 22,99 % |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Morgan Stanley from $50.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€37.40
29.09.25
29.09.25
€65.69
29.09.26
29.09.26
96.04%
12.08.26
12.08.26
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€39.40
06.01.26
06.01.26
€68.23
06.01.27
06.01.27
86.09%
12.08.26
12.08.26